BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24900294)

  • 1. Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.
    Richardson TI; Clarke CA; Yu KL; Yee YK; Bleisch TJ; Lopez JE; Jones SA; Hughes NE; Muehl BS; Lugar CW; Moore TL; Shetler PK; Zink RW; Osborne JJ; Montrose-Rafizadeh C; Patel N; Geiser AG; Galvin RJ; Dodge JA
    ACS Med Chem Lett; 2011 Feb; 2(2):148-53. PubMed ID: 24900294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
    Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel mechanism of steroid receptor antagonism: WAY-255348 modulates progesterone receptor cellular localization and promoter interactions.
    Yudt MR; Russo LA; Berrodin TJ; Jelinsky SA; Ellis D; Cohen JC; Cooch N; Haglund E; Unwalla RJ; Fensome A; Wrobel J; Zhang Z; Nagpal S; Winneker RC
    Biochem Pharmacol; 2011 Dec; 82(11):1709-19. PubMed ID: 21854761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.
    Zhang Z; Lundeen SG; Slayden O; Zhu Y; Cohen J; Berrodin TJ; Bretz J; Chippari S; Wrobel J; Zhang P; Fensome A; Winneker RC; Yudt MR
    Ernst Schering Found Symp Proc; 2007; (1):171-97. PubMed ID: 18540573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
    Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Lundeen S; Marschke KB; Zhang Z
    J Med Chem; 2002 Sep; 45(20):4379-82. PubMed ID: 12238914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.
    Kraus WL; Katzenellenbogen BS
    Endocrinology; 1993 Jun; 132(6):2371-9. PubMed ID: 8504742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery, chemistry, and reproductive pharmacology of asoprisnil and related 11beta-benzaldoxime substituted selective progesterone receptor modulators (SPRMs).
    Schubert G; Elger W; Kaufmann G; Schneider B; Reddersen G; Chwalisz K
    Semin Reprod Med; 2005 Feb; 23(1):58-73. PubMed ID: 15714390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system.
    Afhüppe W; Sommer A; Müller J; Schwede W; Fuhrmann U; Möller C
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):105-15. PubMed ID: 19130882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.
    Fensome A; Koko M; Wrobel J; Zhang P; Zhang Z; Cohen J; Lundeen S; Rudnick K; Zhu Y; Winneker R
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1317-20. PubMed ID: 12657272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct temporal and spatial activities of RU486 on progesterone receptor function in reproductive organs of ovariectomized mice.
    Han SJ; Tsai SY; Tsai MJ; O'Malley BW
    Endocrinology; 2007 May; 148(5):2471-86. PubMed ID: 17303655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activities of 2,3,7,8-tetrachlorodibenzo-p-dioxin and progesterone as antiestrogens in the female rat uterus.
    Romkes M; Safe S
    Toxicol Appl Pharmacol; 1988 Mar; 92(3):368-80. PubMed ID: 2832970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486.
    O'Connor JC; Davis LG; Frame SR; Cook JC
    Toxicol Sci; 2000 Apr; 54(2):338-54. PubMed ID: 10774816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational developments for the treatment of progesterone-dependent diseases.
    Möller C; Hoffmann J; Kirkland TA; Schwede W
    Expert Opin Investig Drugs; 2008 Apr; 17(4):469-79. PubMed ID: 18363513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
    Madauss KP; Grygielko ET; Deng SJ; Sulpizio AC; Stanley TB; Wu C; Short SA; Thompson SK; Stewart EL; Laping NJ; Williams SP; Bray JD
    Mol Endocrinol; 2007 May; 21(5):1066-81. PubMed ID: 17356170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.
    Ng SSM; Jorge S; Malik M; Britten J; Su SC; Armstrong CR; Brennan JT; Chang S; Baig KM; Driggers PH; Segars JH
    J Clin Endocrinol Metab; 2019 Mar; 104(3):970-980. PubMed ID: 30239831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-uterine interactions: an assessment of androgen interaction with the testosterone- and estrogen-receptor systems and stimulation of uterine growth and progesterone-receptor synthesis.
    Schmidt WN; Katzenellenbogen BS
    Mol Cell Endocrinol; 1979 Aug; 15(2):91-108. PubMed ID: 499651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.